User profiles for L. Schneider

Lynda Schneider

Verified email at childrens.harvard.edu
Cited by 18029

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

…, Q Samus, LS Schneider, G Selbæk, L Teri… - The Lancet, 2020 - thelancet.com
The number of older people, including those living with dementia, is rising, as younger age
mortality declines. However, the age-specific incidence of dementia has fallen in many …

Dementia prevention, intervention, and care

…, Q Samus, LS Schneider, G Selbæk, L Teri… - The lancet, 2017 - thelancet.com
Executive summary Acting now on dementia prevention, intervention, and care will vastly
improve living and dying for individuals with dementia and their families, and in doing so …

Defeating Alzheimer's disease and other dementias: a priority for European science and society

…, C Qiu, TP Sakmar, P Scheltens, LS Schneider… - The Lancet …, 2016 - thelancet.com
Alzheimer's disease (AD) is the leading cause of dementia, and because the primary risk
factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing …

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

…, B Vellas, PJ Visser, L Schneider… - The Lancet …, 2014 - thelancet.com
In the past 8 years, both the International Working Group (IWG) and the US National Institute
on Aging–Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's …

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

…, PL De Jager, D Evans, JA Schneider… - Nature …, 2011 - nature.com
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

[HTML][HTML] A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease

…, CW Cotman, E Pfeiffer, LS Schneider… - … England Journal of …, 1997 - Mass Medical Soc
Background There is evidence that medications or vitamins that increase the levels of brain
catecholamines and protect against oxidative damage may reduce the neuronal damage …

Cytokine modulation of atopic dermatitis filaggrin skin expression

…, M Boguniewicz, A DeBenedetto, L Schneider… - Journal of Allergy and …, 2009 - Elsevier
… Protein was isolated from primary keratinocytes by acetone precipitation and washed by
using 0.3 mol/L guanidine hydrochloride in 95% ethanol with 2.5% glycerol according to the …

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease

…, R Stone, P Winner, L Maté, C Lessard, L Schneider… - Jama, 1994 - jamanetwork.com
Objective. —To evaluate the efficacy and safety of high-dose tacrine hydrochloride over 30
weeks in patients with probable Alzheimer's disease. Design. —A 30-week randomized, …

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

LS Schneider, KS Dagerman, P Insel - Jama, 2005 - jamanetwork.com
… Author Contributions: Dr Schneider had full access to all of the data in the study and
takes responsibility for the integrity of the data and the accuracy of the data analysis. …

Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria

…, C Rowe, S Salloway, LS Schneider… - Alzheimer's & …, 2016 - Elsevier
During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD)
considering the disease as a continuum. Thanks to evolving biomarker research and …